In ovarian cancer, CXCR4 and CXCL12 overexpression is linked with tumor cell proliferation and the CXCL12/CXCR4 signaling affects the anti-tumor immunity [81]. This evidence concerns the gene CXCL12 and ovarian carcinoma.